Nancy Davis (@nbdavismd) 's Twitter Profile
Nancy Davis

@nbdavismd

Sr. Prin. Scientist, MSD, Bladder Cancer

Tweets are my own & do not represent any organization or institution. RT are not endorsements.

ID: 2494893802

calendar_today19-04-2014 14:36:48

215 Tweet

389 Takipçi

274 Takip Edilen

Nancy Davis (@nbdavismd) 's Twitter Profile Photo

So sad. Testicular cancer is generally curable. But when it's not, it is awful. Condolences to the family. Actor Tim Roth announces death of son Cormac, age 25: 'A gentle soul' share.newsbreak.com/25xb478p

Amer. Urol. Assn. (@amerurological) 's Twitter Profile Photo

Join the AUA and SUO on Thursday, April 27 in Chicago for a joint symposium exploring the role of PARP Inhibitor treatments. Mark your calendars, dinner is provided with this FREE program! ➡️ bit.ly/3XAIgvY Ashley Ross MD PhD Kristen R. Scarpato Nancy Davis

Join the AUA and SUO on Thursday, April 27 in Chicago for a joint symposium exploring the role of PARP Inhibitor treatments. Mark your calendars, dinner is provided with this FREE program! ➡️ bit.ly/3XAIgvY

<a href="/ashleyrossmdphd/">Ashley Ross MD PhD</a> <a href="/Scarps_kristen/">Kristen R. Scarpato</a> <a href="/NBDavisMD/">Nancy Davis</a>
Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

🤔For newly diagnosed #cancer #patients it is daunting to identify the best #healthcare provider. Here is MY PERSPECTIVE on why choosing ✔️a NCI Center for Cancer Research can be the best initial resource. "How to Choose the Best Cancer Care: mysouthernhealth.com/best-cancer-ce…

Nancy Davis (@nbdavismd) 's Twitter Profile Photo

Spinning next Saturday to raise money for cancer research Vanderbilt-Ingram Cancer Center. Please consider sponsoring me as I try to give my all and not breathe my last breath... give.vanderbilthealth.org/fundraiser/422…

Brian Rini, MD (@brian_rini) 's Twitter Profile Photo

Come join the Vanderbilt team! We are looking for an early/mid-career GU Medical Oncologist with a bladder cancer focus. careercenter.asco.org/job/7618295/vu….

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

JUST IN: Belzutifan 005 trial from Merck shows superior PFS/ORR compared ro everolimus ! Results are in ! businesswire.com/news/home/2023…

JUST IN: Belzutifan 005 trial from <a href="/Merck/">Merck</a> shows superior PFS/ORR compared ro everolimus ! Results are in ! 

businesswire.com/news/home/2023…
Tom Powles (@tompowles1) 's Twitter Profile Photo

EV302- enfortumab vedotin and Pembrolizumab met its dual primary endpoints of OS and PFS with ‘clinically meaningful’ improvement versus chemotherapy in patients with previously untreated la/mUC. merck.com/news/merck-ann…

Kimryn Rathmell (@kimrynrathmell) 's Twitter Profile Photo

Latest and greatest in GU Oncology 🧡🧡🧡, by the ones really making it happen. GU Oncology Rising ⭐️🌟⭐️🌟⭐️ 👇👇👇👇

Tom Powles (@tompowles1) 's Twitter Profile Photo

New ESMO - Eur. Oncology guidlines for advanced bladder cancer Annals of Oncology. Enforumab Vedotin & pembro is the new standard of care. Platinum therapy is now 2nd line and eligibility less relevant. Gem/cis/nivo or maintenance avelumab for pts where EVP not available annalsofoncology.org/article/S0923-…

New <a href="/myESMO/">ESMO - Eur. Oncology</a> guidlines for advanced bladder cancer <a href="/Annals_Oncology/">Annals of Oncology</a>. Enforumab Vedotin &amp; pembro is the new standard of care. Platinum therapy is now 2nd line and eligibility less relevant. Gem/cis/nivo or maintenance avelumab for pts where EVP not available annalsofoncology.org/article/S0923-…
OncLive.com (@onclive) 's Twitter Profile Photo

First-line treatment with Versamune HPV and pembrolizumab met the primary end point of best overall response in the phase 2 VERSATILE-002 trial in HPV6–positive recurrent/metastatic HNSCC.#hnscc #oncology onclive.com/view/first-lin…

First-line treatment with Versamune HPV and pembrolizumab met  the primary end point of best overall response in the phase 2 VERSATILE-002 trial in HPV6–positive recurrent/metastatic HNSCC.#hnscc #oncology onclive.com/view/first-lin…
OncLive.com (@onclive) 's Twitter Profile Photo

Telemedicine Allows for First-of-its-Kind Trial Administering Subcutaneous Immunotherapy at Home Jorge Nieva USC Norris Comprehensive Cancer Center #oncology #MedTwitter #lcsm onclive.com/view/telemedic…

SWOG Cancer Research Network (@swog) 's Twitter Profile Photo

From SWOG Cancer Research Network S1314: Bladder cancer tumors w changes in any of 3 DNA damage-repair genes were >5X as likely to be cleared by neoadj cisplatin-based chemo. Could help ID patients who could trade bladder removal for surveillance. Results in European Urology. swog.org/news-events/ne…

From <a href="/SWOG/">SWOG Cancer Research Network</a> S1314: Bladder cancer tumors w changes in any of 3 DNA damage-repair genes were &gt;5X as likely to be cleared by neoadj cisplatin-based chemo. Could help ID patients who could trade bladder removal for surveillance. Results in <a href="/EUplatinum/">European Urology</a>.
swog.org/news-events/ne…
Alan Tan (@alantanmd) 's Twitter Profile Photo

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding. We are seeking a GU medical oncology clinical investigator to join our innovative team. Please message me or Brian Rini, MD to inquire further. We will also be at #ESMO24

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding.  We are seeking a GU medical oncology clinical investigator to join our innovative team.  Please message me or <a href="/brian_rini/">Brian Rini, MD</a> to inquire further.  We will also be at #ESMO24